Atıf Formatları
Evaluation of periostin, fibronectin and tenascin-C in patients chronic otitis media with cholesteatoma
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. Birinci Et Al. , "Evaluation of periostin, fibronectin and tenascin-C in patients chronic otitis media with cholesteatoma," Egyptian Journal of Otolaryngology , vol.38, no.1, 2022

Birinci, M. Et Al. 2022. Evaluation of periostin, fibronectin and tenascin-C in patients chronic otitis media with cholesteatoma. Egyptian Journal of Otolaryngology , vol.38, no.1 .

Birinci, M., Terzi, S., Demir, E., ÇELİKER, M., OKCU, O., ARPA, M., ... Çelebi, Ö.(2022). Evaluation of periostin, fibronectin and tenascin-C in patients chronic otitis media with cholesteatoma. Egyptian Journal of Otolaryngology , vol.38, no.1.

Birinci, Mehmet Et Al. "Evaluation of periostin, fibronectin and tenascin-C in patients chronic otitis media with cholesteatoma," Egyptian Journal of Otolaryngology , vol.38, no.1, 2022

Birinci, Mehmet Et Al. "Evaluation of periostin, fibronectin and tenascin-C in patients chronic otitis media with cholesteatoma." Egyptian Journal of Otolaryngology , vol.38, no.1, 2022

Birinci, M. Et Al. (2022) . "Evaluation of periostin, fibronectin and tenascin-C in patients chronic otitis media with cholesteatoma." Egyptian Journal of Otolaryngology , vol.38, no.1.

@article{article, author={Mehmet Birinci Et Al. }, title={Evaluation of periostin, fibronectin and tenascin-C in patients chronic otitis media with cholesteatoma}, journal={Egyptian Journal of Otolaryngology}, year=2022}